AP1S3

AP1S3 encodes σ1C, a sigma subunit of the AP-1 clathrin adaptor complex that governs endosomal membrane trafficking in keratinocytes, where its loss drives cutaneous autoinflammation (PMID:24791904, PMID:27388993). AP1S3 is required for endosomal translocation of TLR3, and its depletion mislocalizes TLR3 and blunts downstream TLR3 signaling (PMID:24791904). Independently, AP1S3 loss-of-function disrupts keratinocyte autophagy, causing accumulation of the autophagy adaptor p62, which activates NF-κB and drives overexpression of IL-36α; this cascade is recapitulated by pharmacological autophagy inhibition and reversed by IL-36 blockade in patient keratinocytes, defining the mechanistic route from adaptor dysfunction to autoinflammatory disease (PMID:27388993). Beyond its keratinocyte role, AP1S3 physically binds the HCV E2 envelope protein and shields it from E6AP-mediated ubiquitin-dependent proteasomal degradation, and a synthetic peptide carrying the AP1S3-recognized motif inhibits HCV infection (PMID:27079945).

1. 2014 Medium

   Established the first cellular function of AP1S3 by showing the AP-1 σ1C subunit is needed to deliver TLR3 to the endosomal compartment where it signals.

   Evidence AP1S3 siRNA knockdown in keratinocyte lines with TLR3 localization and signaling readouts

   PMID:24791904

   Open questions at the time

   • Did not define the cargo-recognition motif on TLR3 bound by AP1S3
   • Did not establish how AP1S3 loss-of-function alleles translate to disease in patients
   • No structural or reconstitution evidence for the AP-1/σ1C–TLR3 interaction
2. 2016 High

   Connected AP1S3 dysfunction to autoinflammatory disease mechanism by placing it upstream of an autophagy → p62 → NF-κB → IL-36α cascade in keratinocytes.

   Evidence AP1S3 gene silencing and knockout in keratinocytes, p62/NF-κB/IL-36α assays, pharmacological autophagy inhibition, patient cells, and IL-36 blockade rescue

   PMID:27388993

   Open questions at the time

   • Molecular link between AP-1 trafficking defect and impaired autophagosome formation not defined
   • Relationship between the TLR3-trafficking role and the autophagy role not reconciled
   • Does not identify the AP1S3 trafficking cargo whose loss triggers autophagy failure
3. 2016 Medium

   Revealed a distinct, virus-facing role for AP1S3 in stabilizing HCV E2 by antagonizing its E6AP-mediated proteasomal degradation.

   Evidence Reciprocal Co-IP, AP1S3 siRNA in Huh7.5.1 cells, in vivo ubiquitylation assay, and synthetic peptide HCV inhibition

   PMID:27079945

   Open questions at the time

   • Single lab without independent confirmation of the E2–AP1S3 interaction
   • Mechanism by which AP1S3 sterically or competitively blocks E6AP ubiquitylation unresolved
   • Physiological relevance of AP1S3 in hepatocyte trafficking beyond HCV not addressed
4. 2025 Low

   Proposed a pro-tumorigenic role for AP1S3 in breast cancer cells via PI3K/AKT/mTOR-driven lipid metabolism.

   Evidence AP1S3 siRNA knockdown in MDA-MB-231/MDA-MB-436 cells with proliferation, migration, lipid droplet, and pathway marker readouts

   PMID:40555003

   Open questions at the time

   • Single paper, single lab, no reconstitution or mutagenesis to establish direct causality
   • Pathway placement rests on downstream marker measurement rather than direct interaction
   • Mechanistic link between an AP-1 adaptor subunit and PI3K/AKT/mTOR activation undefined

• How a single AP-1 sigma subunit reconciles its roles in TLR3 endosomal sorting, autophagosome formation, and HCV E2 stabilization, and what redundancy exists among σ1A/σ1B/σ1C, remains unresolved.
• No direct functional comparison of σ1C against σ1A/σ1B in keratinocytes
• No structural model of σ1C cargo recognition
• Unifying molecular mechanism linking trafficking defects to autophagy failure not established